Advances in stroke pharmacology

Pharmacology and Therapeutics

Volumn 191, Issue , 2018, Pages 23-42

  Zhou, Zhenhua ^b,e   Lu, Jianfei ^a   Liu, Wen Wu ^c   Manaenko, Anatol ^d   Hou, Xianhua ^e   Mei, Qiyong ^f   Huang, Jun Long ^a   Tang, Jiping ^b   Zhang, John H ^b   Yao, Honghong ^g   Hu, Qin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e THIRD MILITARY MEDICAL UNIVERSITY   (China)

^f SECOND MILITARY MEDICAL UNIVERSITY   (China)

^g MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Animal studies; Clinical trials; Neuroprotection; Pharmacology; Stroke

Indexed keywords

CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; FIBRINOLYTIC AGENT; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITROGEN DERIVATIVE; REACTIVE OXYGEN METABOLITE; SODIUM CALCIUM EXCHANGE PROTEIN; NEUROPROTECTIVE AGENT;

ADAPTIVE IMMUNITY; ANGIOGENESIS; APOPTOSIS; ARTERY OCCLUSION; AUTOPHAGY; BASIC RESEARCH; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CALCIUM TRANSPORT; CEREBRAL REVASCULARIZATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); DRUG THERAPY; EXCITOTOXICITY; FIBRINOLYTIC THERAPY; HUMAN; INNATE IMMUNITY; NECROPTOSIS; NERVE CELL PLASTICITY; NERVE SPROUTING; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECANALIZATION; REVIEW; SIGNAL TRANSDUCTION; TRANSLATIONAL RESEARCH; ANIMAL; DRUG DEVELOPMENT; MOLECULARLY TARGETED THERAPY; PROCEDURES;

ANIMALS; BRAIN ISCHEMIA; DRUG DEVELOPMENT; HUMANS; MOLECULAR TARGETED THERAPY; NEUROPROTECTIVE AGENTS; STROKE; TRANSLATIONAL MEDICAL RESEARCH;

EID: 85048896264     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2018.05.012     Document Type: Review

References (321)

1. Abdelkarim, G.E., Gertz, K., Harms, C., Katchanov, J., Dirnagl, U., Szabo, C., Endres, M., Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. International Journal of Molecular Medicine 7 (2001), 255–260.
2. Adams, H.P. Jr., Bendixen, B.H., Kappelle, L.J., Biller, J., Love, B.B., Gordon, D.L., Marsh, E.E. III, Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke 24 (1993), 35–41.
3. Adams, K.L., Gallo, V., The diversity and disparity of the glial scar. Nature Neuroscience 21 (2018), 9–15.
4. Akgul, G., McBain, C.J., Diverse roles for ionotropic glutamate receptors on inhibitory interneurons in developing and adult brain. The Journal of Physiology 594 (2016), 5471–5490.
5. Alafaci, C., Salpietro, F., Grasso, G., Sfacteria, A., Passalacqua, M., Morabito, A., Tomasello, F., Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage. European Journal of Pharmacology 406 (2000), 219–225.
6. Albers, G.W., Marks, M.P., Kemp, S., Christensen, S., Tsai, J.P., Ortega-Gutierrez, S., et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. The New England Journal of Medicine 378 (2018), 708–718.
7. Alexandrov, A.V., Grotta, J.C., Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 59 (2002), 862–867.
8. Allan, S.M., Tyrrell, P.J., Rothwell, N.J., Interleukin-1 and neuronal injury. Nature Reviews. Immunology 5 (2005), 629–640.
9. Amaro, S., Laredo, C., Renu, A., Llull, L., Rudilosso, S., Obach, V., Investigators, U.-I., Uric acid therapy prevents early ischemic stroke progression: A tertiary analysis of the URICO-ICTUS trial (efficacy study of combined treatment with uric acid and r-tPA in acute ischemic stroke). Stroke 47 (2016), 2874–2876.
10. Amaro, S., Llull, L., Renu, A., Laredo, C., Perez, B., Vila, E., Chamorro, A., Uric acid improves glucose-driven oxidative stress in human ischemic stroke. Annals of Neurology 77 (2015), 775–783.
11. Andersen, L.P., Gogenur, I., Rosenberg, J., Reiter, R.J., The safety of melatonin in humans. Clinical Drug Investigation 36 (2016), 169–175.
12. Andrabi, S.S., Parvez, S., Tabassum, H., Melatonin and ischemic stroke: Mechanistic roles and action. Advances in Pharmacological Sciences, 2015, 2015, 384750.
13. Bai, Y., Zhang, Y., Han, B., Yang, L., Chen, X., Huang, R., et al. Circular RNA DLGAP4 ameliorates ischemic stroke outcomes by targeting miR-143 to regulate endothelial-mesenchymal transition associated with blood-brain barrier integrity. The Journal of Neuroscience 38 (2018), 32–50.
14. Bailey, D.M., Lundby, C., Berg, R.M., Taudorf, S., Rahmouni, H., Gutowski, M., et al. On the antioxidant properties of erythropoietin and its association with the oxidative-nitrosative stress response to hypoxia in humans. Acta Physiologica (Oxford, England) 212 (2014), 175–187.
15. Bandera, E., Botteri, M., Minelli, C., Sutton, A., Abrams, K.R., Latronico, N., Cerebral blood flow threshold of ischemic penumbra and infarct core in acute ischemic stroke: A systematic review. Stroke 37 (2006), 1334–1339.
16. Barreto, G., White, R.E., Ouyang, Y., Xu, L., Giffard, R.G., Astrocytes: Targets for neuroprotection in stroke. Central Nervous System Agents in Medicinal Chemistry 11 (2011), 164–173.
17. Becker, B.F., Towards the physiological function of uric acid. Free Radical Biology & Medicine 14 (1993), 615–631.
18. Bennett, D.A., Krishnamurthi, R.V., Barker-Collo, S., Forouzanfar, M.H., Naghavi, M., Connor, M., et al. The global burden of ischemic stroke: Findings of the GBD 2010 study. Global Heart 9 (2014), 107–112.
19. Berkhemer, O.A., Fransen, P.S., Beumer, D., van den Berg, L.A., Lingsma, H.F., Yoo, A.J., et al. A randomized trial of intraarterial treatment for acute ischemic stroke. The New England Journal of Medicine 372 (2015), 11–20.
20. Bhambri, P., Sarvi, A., Wong, J.H., Sundararaj, U., Mitha, A.P., Verapamil eluting stents as a possible treatment for vasospasm after subarachnoid hemorrhage. Journal of NeuroInterventional Surgery 9 (2017), 875–879.
21. Bohacek, I., Cordeau, P., Lalancette-Hebert, M., Gorup, D., Weng, Y.C., Gajovic, S., Kriz, J., Toll-like receptor 2 deficiency leads to delayed exacerbation of ischemic injury. Journal of Neuroinflammation, 9, 2012, 191.
22. Brodsky, S.J., Cutler, S.S., Weiner, D.A., McCabe, C.H., Ryan, T.J., Klein, M.D., Treatment of stable angina of effort with verapamil: A double-blind, placebo-controlled randomized crossover study. Circulation 66 (1982), 569–574.
23. Bubenik, G.A., Konturek, S.J., Melatonin and aging: Prospects for human treatment. Journal of Physiology and Pharmacology 62 (2011), 13–19.
24. Buckley, K.M., Hess, D.L., Sazonova, I.Y., Periyasamy-Thandavan, S., Barrett, J.R., Kirks, R., et al. Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke. Experimental & Translational Stroke Medicine, 6, 2014, 8.
25. Campbell, B.C., Mitchell, P.J., Kleinig, T.J., Dewey, H.M., Churilov, L., Yassi, N., et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. The New England Journal of Medicine 372 (2015), 1009–1018.
26. Cao, S., Shrestha, S., Li, J., Yu, X., Chen, J., Yan, F., Ying, G., Gu, C., Wang, L., Chen, G., Melatonin-mediated mitophagy protects against early brain injury after subarachnoid hemorrhage through inhibition of NLRP3 inflammasome activation. Sci Rep, 7, 2017, 2417.
27. Castillo, C., Zaror, S., Gonzalez, M., Hidalgo, A., Burgos, C.F., Cabezas, O.I., et al. Neuroprotective effect of a new variant of Epo nonhematopoietic against oxidative stress. Redox Biology 14 (2018), 285–294.
28. Chamorro, A., Amaro, S., Castellanos, M., Segura, T., Arenillas, J., Marti-Fabregas, J., et al. Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): A randomised, double-blind phase 2b/3 trial. Lancet Neurology 13 (2014), 453–460.
29. Chamorro, A., Dirnagl, U., Urra, X., Planas, A.M., Neuroprotection in acute stroke: Targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. Lancet Neurology 15 (2016), 869–881.
30. Chassagnon, I.R., McCarthy, C.A., Chin, Y.K., Pineda, S.S., Keramidas, A., Mobli, M., et al. Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a. Proceedings of the National Academy of Sciences of the United States of America 114 (2017), 3750–3755.
31. Chen, C.K., Hsu, P.Y., Wang, T.M., Miao, Z.F., Lin, R.T., Juo, S.H., TRPV4 activation contributes functional recovery from ischemic stroke via angiogenesis and neurogenesis. Molecular Neurobiology 55 (2017), 4127–4135.
32. Chen, F., Zhang, L., Wang, E., Zhang, C., Li, X., LncRNA GAS5 regulates ischemic stroke as a competing endogenous RNA for miR-137 to regulate the Notch1 signaling pathway. Biochemical and Biophysical Research Communications 496 (2018), 184–190.
33. Chen, J., Zhang, C., Jiang, H., Li, Y., Zhang, L., Robin, A., Chopp, M., Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. Journal of Cerebral Blood Flow and Metabolism 25 (2005), 281–290.
34. Chen, S., Wu, H., Klebe, D., Hong, Y., Zhang, J., Tang, J., Regulatory T cell in stroke: A new paradigm for immune regulation. Clinical & Developmental Immunology, 2013, 2013, 689827.
35. Chen, Z.Q., Mou, R.T., Feng, D.X., Wang, Z., Chen, G., The role of nitric oxide in stroke. Medical Gas Research 7 (2017), 194–203.
36. Cheon, S.Y., Cho, K.J., Kim, S.Y., Kam, E.H., Lee, J.E., Koo, B.N., Blockade of apoptosis signal-regulating kinase 1 attenuates matrix metalloproteinase 9 activity in brain endothelial cells and the subsequent apoptosis in neurons after ischemic injury. Frontiers in Cellular Neuroscience, 10, 2016, 213.
37. Cheon, S.Y., Kim, E.J., Kim, J.M., Kam, E.H., Ko, B.W., Koo, B.N., Regulation of microglia and macrophage polarization via apoptosis signal-regulating kinase 1 silencing after ischemic/hypoxic injury. Frontiers in Molecular Neuroscience, 10, 2017, 261.
38. Chopp, M., Orchestrating recovery: Cell-based therapy for stroke. Translational Stroke Research 2 (2011), 241–242.
39. Collino, M., Patel, N.S., Thiemermann, C., PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury. Therapeutic Advances in Cardiovascular Disease 2 (2008), 179–197.
40. Connolly, E.S. Jr., Winfree, C.J., Prestigiacomo, C.J., Kim, S.C., Choudhri, T.F., Hoh, B.L., Pinsky, D.J., Exacerbation of cerebral injury in mice that express the P-selectin gene: Identification of P-selectin blockade as a new target for the treatment of stroke. Circulation Research 81 (1997), 304–310.
41. Connolly, E.S. Jr., Winfree, C.J., Springer, T.A., Naka, Y., Liao, H., Yan, S.D., Pinsky, D.J., Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. The Journal of Clinical Investigation 97 (1996), 209–216.
42. Cook, D.J., Tymianski, M., Translating promising preclinical neuroprotective therapies to human stroke trials. Expert Review of Cardiovascular Therapy 9 (2011), 433–449.
43. Cull-Candy, S., Brickley, S., Farrant, M., NMDA receptor subunits: Diversity, development and disease. Current Opinion in Neurobiology 11 (2001), 327–335.
44. Damgaard, M., Haugaard, A.S., Kickinger, S., Al-Khawaja, A., Lie, M.E.K., Ecker, G.F., Frolund, B., Development of non-GAT1-selective inhibitors: Challenges and achievements. Advances in Neurobiology 16 (2017), 315–332.
45. Darmani, G., Zipser, C.M., Bohmer, G.M., Deschet, K., Muller-Dahlhaus, F., Belardinelli, P., Ziemann, U., Effects of the selective alpha5-GABAAR antagonist S44819 on excitability in the human brain: A TMS-EMG and TMS-EEG phase I study. The Journal of Neuroscience 36 (2016), 12312–12320.
46. Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Yuan, J., Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nature Chemical Biology 1 (2005), 112–119.
47. Demarest, T.G., Waite, E.L., Kristian, T., Puche, A.C., Waddell, J., McKenna, M.C., Fiskum, G., Sex-dependent mitophagy and neuronal death following rat neonatal hypoxia-ischemia. Neuroscience 335 (2016), 103–113.
48. Di, Y., He, Y.L., Zhao, T., Huang, X., Wu, K.W., Liu, S.H., Zhao, Y.Q., Fan, M., Wu, L.Y., Zhu, L.L., Methylene Blue Reduces Acute Cerebral Ischemic Injury via the Induction of Mitophagy. Mol Med 21 (2015), 420–429.
49. Dirnagl, U., Iadecola, C., Moskowitz, M.A., Pathobiology of ischaemic stroke: An integrated view. Trends in Neurosciences 22 (1999), 391–397.
50. Dong, W., Xian, Y., Yuan, W., Huifeng, Z., Tao, W., Zhiqiang, L., et al. Catalpol stimulates VEGF production via the JAK2/STAT3 pathway to improve angiogenesis in rats’ stroke model. Journal of Ethnopharmacology 191 (2016), 169–179.
51. Dong, Y., Fan, C., Hu, W., Jiang, S., Ma, Z., Yan, X., et al. Melatonin attenuated early brain injury induced by subarachnoid hemorrhage via regulating NLRP3 inflammasome and apoptosis signaling. Journal of Pineal Research 60 (2016), 253–262.
52. Dou, Y., Wang, Z., Chen, G., The role of hydrogen sulfide in stroke. Medical Gas Research 6 (2016), 79–84.
53. Duricki, D.A., Hutson, T.H., Kathe, C., Soleman, S., Gonzalez-Carter, D., Petruska, J.C., et al. Delayed intramuscular human neurotrophin-3 improves recovery in adult and elderly rats after stroke. Brain 139 (2016), 259–275.
54. During, M.J., Symes, C.W., Lawlor, P.A., Lin, J., Dunning, J., Fitzsimons, H.L., et al. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science 287 (2000), 1453–1460.
55. Elmaraezy, A., Abushouk, A.I., Saad, S., Eltoomy, M., Mahmoud, O., Hassan, H.M., et al. Desmoteplase for acute ischemic stroke: A systematic review and metaanalysis of randomized controlled trials. CNS & Neurological Disorders Drug Targets 16 (2017), 789–799.
56. Emsley, H.C., Smith, C.J., Georgiou, R.F., Vail, A., Hopkins, S.J., Rothwell, N.J., Acute Stroke, I., A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. Journal of Neurology, Neurosurgery, and Psychiatry 76 (2005), 1366–1372.
57. Espinera, A.R., Ogle, M.E., Gu, X., Wei, L., Citalopram enhances neurovascular regeneration and sensorimotor functional recovery after ischemic stroke in mice. Neuroscience 247 (2013), 1–11.
58. Fang, Z., He, Q.W., Li, Q., Chen, X.L., Baral, S., Jin, H.J., et al. MicroRNA-150 regulates blood-brain barrier permeability via Tie-2 after permanent middle cerebral artery occlusion in rats. The FASEB Journal 30 (2016), 2097–2107.
59. Farrant, M., Nusser, Z., Variations on an inhibitory theme: Phasic and tonic activation of GABA(A) receptors. Nature Reviews. Neuroscience 6 (2005), 215–229.
60. Fayaz, S.M., Suvanish Kumar, V.S., Rajanikant, G.K., Necroptosis: Who knew there were so many interesting ways to die?. CNS & Neurological Disorders Drug Targets 13 (2014), 42–51.
61. Feigin, V.L., Forouzanfar, M.H., Krishnamurthi, R., Mensah, G.A., Connor, M., Bennett, D.A., et al. Global and regional burden of stroke during 1990-2010: Findings from the global burden of disease study 2010. Lancet 383 (2014), 245–254.
62. Feng, D., Wang, B., Wang, L., Abraham, N., Tao, K., Huang, L., Qu, Y., Pre-ischemia melatonin treatment alleviated acute neuronal injury after ischemic stroke by inhibiting endoplasmic reticulum stress-dependent autophagy via PERK and IRE1 signalings. Journal of Pineal Research, 62, 2017 (jpi.12395).
63. Feng, J., Chen, X., Shen, J., Reactive nitrogen species as therapeutic targets for autophagy: Implication for ischemic stroke. Expert Opinion on Therapeutic Targets 21 (2017), 305–317.
64. Fiorina, P., Lattuada, G., Ponari, O., Silvestrini, C., DallAglio, P., Impaired nocturnal melatonin excretion and changes of immunological status in ischaemic stroke patients. Lancet 347 (1996), 692–693.
65. Foley, L.M., Hitchens, T.K., Barbe, B., Zhang, F., Ho, C., Rao, G.R., Nemoto, E.M., Quantitative temporal profiles of penumbra and infarction during permanent middle cerebral artery occlusion in rats. Translational Stroke Research 1 (2010), 220–229.
66. Ford, A.L., An, H., Vo, K.D., Lin, W., Lee, J.M., Defining the ischemic penumbra using hyperacute neuroimaging: Deriving quantitative ischemic thresholds. Translational Stroke Research 3 (2012), 198–204.
67. Fraser, J.F., Maniskas, M., Trout, A., Lukins, D., Parker, L., Stafford, W.L., Bix, G.J., Intra-arterial verapamil post-thrombectomy is feasible, safe, and neuroprotective in stroke. Journal of Cerebral Blood Flow and Metabolism 37 (2017), 3531–3543.
68. Frugier, T., Taylor, J.M., McLean, C., Bye, N., Beart, P.M., Devenish, R.J., Crack, P.J., Evidence for the recruitment of autophagic vesicles in human brain after stroke. Neurochemistry International 96 (2016), 62–68.
69. Fu, Y., Liu, Q., Anrather, J., Shi, F.D., Immune interventions in stroke. Nature Reviews. Neurology 11 (2015), 524–535.
70. Fuchs, Y., Steller, H., Live to die another way: Modes of programmed cell death and the signals emanating from dying cells. Nature Reviews. Molecular Cell Biology 16 (2015), 329–344.
71. Fukuta, T., Asai, T., Sato, A., Namba, M., Yanagida, Y., Kikuchi, T., Oku, N., Neuroprotection against cerebral ischemia/reperfusion injury by intravenous administration of liposomal fasudil. International Journal of Pharmaceutics 506 (2016), 129–137.
72. Fukuta, T., Asai, T., Yanagida, Y., Namba, M., Koide, H., Shimizu, K., Oku, N., Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke. The FASEB Journal 31 (2017), 1879–1890.
73. Fukuta, T., Yanagida, Y., Asai, T., Oku, N., Co-administration of liposomal fasudil and tissue plasminogen activator ameliorated ischemic brain damage in occlusion model rats prepared by photochemically induced thrombosis. Biochemical and Biophysical Research Communications 495 (2017), 873–877.
74. Galluzzi, L., Bravo-San Pedro, J.M., Levine, B., Green, D.R., Kroemer, G., Pharmacological modulation of autophagy: Therapeutic potential and persisting obstacles. Nature Reviews. Drug Discovery 16 (2017), 487–511.
75. Gan, Y., Liu, Q., Wu, W., Yin, J.X., Bai, X.F., Shen, R., et al. Ischemic neurons recruit natural killer cells that accelerate brain infarction. Proceedings of the National Academy of Sciences of the United States of America 111 (2014), 2704–2709.
76. Gao, J., Duan, B., Wang, D.G., Deng, X.H., Zhang, G.Y., Xu, L., Xu, T.L., Coupling between NMDA receptor and acid-sensing ion channel contributes to ischemic neuronal death. Neuron 48 (2005), 635–646.
77. Garcia, J.H., Liu, K.F., Relton, J.K., Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. The American Journal of Pathology 147 (1995), 1477–1486.
78. Gaudin, A., Yemisci, M., Eroglu, H., Lepetre-Mouelhi, S., Turkoglu, O.F., Donmez-Demir, B., et al. Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury. Nature Nanotechnology 9 (2014), 1054–1062.
79. Gogishvili, T., Langenhorst, D., Luhder, F., Elias, F., Elflein, K., Dennehy, K.M., Hunig, T., Rapid regulatory T-cell response prevents cytokine storm in CD28 superagonist treated mice. PLoS One, 4, 2009, e4643.
80. Gonzalez, F.F., McQuillen, P., Mu, D., Chang, Y., Wendland, M., Vexler, Z., Ferriero, D.M., Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Developmental Neuroscience 29 (2007), 321–330.
81. Goyal, M., Demchuk, A.M., Menon, B.K., Eesa, M., Rempel, J.L., Thornton, J., Roy, D., Jovin, T.G., Willinsky, R.A., Sapkota, B.L., et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. The New England Journal of Medicine 372 (2015), 1019–1030.
82. Graham, D.I., McIntosh, T.K., Maxwell, W.L., Nicoll, J.A., Recent advances in neurotrauma. Journal of Neuropathology and Experimental Neurology 59 (2000), 641–651.
83. Green, T.N., Hamilton, J.R., Morel-Kopp, M.C., Zheng, Z., Chen, T.T., Hearn, J.I., et al. Inhibition of NMDA receptor function with an anti-GluN1-S2 antibody impairs human platelet function and thrombosis. Platelets 28 (2017), 799–811.
84. Grotta, J.C., Welch, K.M., Fagan, S.C., Lu, M., Frankel, M.R., Brott, T., Lyden, P.D., Clinical deterioration following improvement in the NINDS rt-PA stroke trial. Stroke 32 (2001), 661–668.
85. Grohm, J., Kim, S.W., Mamrak, U., Tobaben, S., Cassidy-Stone, A., Nunnari, J., Plesnila, N., Culmsee, C., Inhibition of Drp1 provides neuroprotection in vitro and in vivo. Cell Death Differ 19 (2012), 1446–1458.
86. Gu, Z., Cui, J., Brown, S., Fridman, R., Mobashery, S., Strongin, A.Y., Lipton, S.A., A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. The Journal of Neuroscience 25 (2005), 6401–6408.
87. Guo, X., Sesaki, H., Qi, X., Drp1 stabilizes p53 on the mitochondria to trigger necrosis under oxidative stress conditions in vitro and in vivo. Biochem J 461 (2014), 137–146.
88. Guan, Y.F., Wu, C.Y., Fang, Y.Y., Zeng, Y.N., Luo, Z.Y., Li, S.J., Gao, T.M., Neuregulin 1 protects against ischemic brain injury via ErbB4 receptors by increasing GABAergic transmission. Neuroscience 307 (2015), 151–159.
89. Gudasheva, T.A., Povarnina, P., Logvinov, I.O., Antipova, T.A., Seredenin, S.B., Mimetics of brain-derived neurotrophic factor loops 1 and 4 are active in a model of ischemic stroke in rats. Drug Design, Development and Therapy 10 (2016), 3545–3553.
90. Guo, D., Ma, J., Yan, L., Li, T., Li, Z., Han, X., Shui, S., Down-regulation of Lncrna MALAT1 attenuates neuronal cell death through suppressing Beclin1-dependent autophagy by regulating Mir-30a in cerebral ischemic stroke. Cellular Physiology and Biochemistry 43 (2017), 182–194.
91. Guo, Y., He, Y., Tang, B., Ma, K., Cai, Z., Zeng, S., Jiang, X., Effect of using fluoxetine at different time windows on neurological functional prognosis after ischemic stroke. Restorative Neurology and Neuroscience 34 (2016), 177–187.
92. Gupta, S., Sharma, U., Jagannathan, N.R., Gupta, Y.K., Neuroprotective effect of lercanidipine in middle cerebral artery occlusion model of stroke in rats. Experimental Neurology 288 (2017), 25–37.
93. Gupta, Y.K., Gupta, M., Kohli, K., Neuroprotective role of melatonin in oxidative stress vulnerable brain. Indian Journal of Physiology and Pharmacology 47 (2003), 373–386.
94. Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Davalos, A., Guidetti, D., et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. The New England Journal of Medicine 359 (2008), 1317–1329.
95. Haley, E.C. Jr., Lyden, P.D., Johnston, K.C., Hemmen, T.M., Investigators, T.N.K.i.S., A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke. Stroke 36 (2005), 607–612.
96. Haley, M.J., Lawrence, C.B., The blood-brain barrier after stroke: Structural studies and the role of transcytotic vesicles. Journal of Cerebral Blood Flow and Metabolism 37 (2017), 456–470.
97. Hammond, M.D., Ambler, W.G., Ai, Y., Sansing, L.H., alpha4 integrin is a regulator of leukocyte recruitment after experimental intracerebral hemorrhage. Stroke 45 (2014), 2485–2487.
98. Hankey, G.J., Stroke. Lancet 389 (2017), 641–654.
99. Harraz, M.M., Eacker, S.M., Wang, X., Dawson, T.M., Dawson, V.L., MicroRNA-223 is neuroprotective by targeting glutamate receptors. Proceedings of the National Academy of Sciences of the United States of America 109 (2012), 18962–18967.
100. Hase, Y., Okamoto, Y., Fujita, Y., Kitamura, A., Nakabayashi, H., Ito, H., Ihara, M., Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia. Experimental Neurology 233 (2012), 523–533.
101. He, Y., Wan, S., Hua, Y., Keep, R.F., Xi, G., Autophagy after experimental intracerebral hemorrhage. Journal of Cerebral Blood Flow and Metabolism 28 (2008), 897–905.
102. He, Y.T., Tang, B.S., Cai, Z.L., Zeng, S.L., Jiang, X., Guo, Y., Effects of fluoxetine on neural functional prognosis after ischemic stroke: A randomized controlled study in China. Journal of Stroke and Cerebrovascular Diseases 25 (2016), 761–770.
103. Hernandez, C.C., Burgos, C.F., Gajardo, A.H., Silva-Grecchi, T., Gavilan, J., Toledo, J.R., Fuentealba, J., Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: The role of erythropoietin receptor. Neural Regeneration Research 12 (2017), 1381–1389.
104. Hu, W.W., Du, Y., Li, C., Song, Y.J., Zhang, G.Y., Neuroprotection of hypothermia against neuronal death in rat hippocampus through inhibiting the increased assembly of GluR6-PSD95-MLK3 signaling module induced by cerebral ischemia/reperfusion. Hippocampus 18 (2008), 386–397.
105. Huang, B.R., Chang, P.C., Yeh, W.L., Lee, C.H., Tsai, C.F., Lin, C., et al. Anti-neuroinflammatory effects of the calcium channel blocker nicardipine on microglial cells: Implications for neuroprotection. PLoS One, 9, 2014, e91167.
106. Huang, J., Choudhri, T.F., Winfree, C.J., McTaggart, R.A., Kiss, S., Mocco, J., et al. Postischemic cerebrovascular E-selectin expression mediates tissue injury in murine stroke. Stroke 31 (2000), 3047–3053.
107. Huang, M., Cheng, G., Tan, H., Qin, R., Zou, Y., Wang, Y., Zhang, Y., Capsaicin protects cortical neurons against ischemia/reperfusion injury via down-regulating NMDA receptors. Experimental Neurology 295 (2017), 66–76.
108. Huang, R., Zhang, Y., Han, B., Bai, Y., Zhou, R., Gan, G., Yao, H., Circular RNA HIPK2 regulates astrocyte activation via cooperation of autophagy and ER stress by targeting MIR124-2HG. Autophagy 13 (2017), 1722–1741.
109. Huang, X.P., Ding, H., Lu, J.D., Tang, Y.H., Deng, B.X., Deng, C.Q., Autophagy in cerebral ischemia and the effects of traditional Chinese medicine. Journal of Integrative Medicine 13 (2015), 289–296.
110. Hun Lee, J., Won, S., Stein, D.G., Progesterone attenuates thrombin-induced endothelial barrier disruption in the brain endothelial cell line bEnd.3: The role of tight junction proteins and the endothelial protein C receptor. Brain Research 1613 (2015), 73–80.
111. Huuskonen, M.T., Loppi, S., Dhungana, H., Keksa-Goldsteine, V., Lemarchant, S., Korhonen, P., et al. Bexarotene targets autophagy and is protective against thromboembolic stroke in aged mice with tauopathy. Scientific Reports, 6, 2016, 33176.
112. Iaci, J.F., Parry, T.J., Huang, Z., Pavlopoulos, E., Finklestein, S.P., Ren, J., Caggiano, A., An optimized dosing regimen of cimaglermin (neuregulin 1beta3, glial growth factor 2) enhances molecular markers of neuroplasticity and functional recovery after permanent ischemic stroke in rats. Journal of Neuroscience Research 94 (2016), 253–265.
113. Ichim, G., Tait, S.W., A fate worse than death: Apoptosis as an oncogenic process. Nature Reviews. Cancer 16 (2016), 539–548.
114. Ikonomidou, C., Turski, L., Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?. Lancet Neurology 1 (2002), 383–386.
115. Iwasaki, A., Medzhitov, R., Control of adaptive immunity by the innate immune system. Nature Immunology 16 (2015), 343–353.
116. Jeong, H.G., Kim, B.J., Yang, M.H., Han, M.K., Bae, H.J., Lee, S.H., Stroke outcomes with use of antithrombotics within 24 hours after recanalization treatment. Neurology 87 (2016), 996–1002.
117. Jiang, C., Wang, J., Li, X., Liu, C., Chen, N., Hao, Y., Progesterone exerts neuroprotective effects by inhibiting inflammatory response after stroke. Inflammation Research 58 (2009), 619–624.
118. Jin, X., Wang, R.H., Wang, H., Long, C.L., Wang, H., Brain protection against ischemic stroke using choline as a new molecular bypass treatment. Acta Pharmacologica Sinica 36 (2015), 1416–1425.
119. Jovin, T.G., Chamorro, A., Cobo, E., de Miquel, M.A., Molina, C.A., Rovira, A., et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. The New England Journal of Medicine 372 (2015), 2296–2306.
120. Justicia, C., Salas-Perdomo, A., Perez-de-Puig, I., Deddens, L.H., van Tilborg, G.A.F., Castellvi, C., Planas, A.M., Uric acid is protective after cerebral ischemia/reperfusion in hyperglycemic mice. Translational Stroke Research 8 (2017), 294–305.
121. Kalev-Zylinska, M.L., Symes, W., Little, K.C., Sun, P., Wen, D., Qiao, L., Barber, P.A., Stroke patients develop antibodies that react with components of N-methyl-D-aspartate receptor subunit 1 in proportion to lesion size. Stroke 44 (2013), 2212–2219.
122. Kaneko, Y., Pappas, C., Tajiri, N., Borlongan, C.V., Oxytocin modulates GABAAR subunits to confer neuroprotection in stroke in vitro. Scientific Reports, 6, 2016, 35659.
123. Kang, D.H., Kim, Y.W., Hwang, Y.H., Park, S.P., Kim, Y.S., Baik, S.K., Instant reocclusion following mechanical thrombectomy of in situ thromboocclusion and the role of low-dose intra-arterial tirofiban. Cerebrovascular Diseases 37 (2014), 350–355.
124. Khaksar, S., Bigdeli, M.R., Anti-excitotoxic effects of cannabidiol are partly mediated by enhancement of NCX2 and NCX3 expression in animal model of cerebral ischemia. European Journal of Pharmacology 794 (2017), 270–279.
125. Khandelwal, P., Yavagal, D.R., Sacco, R.L., Acute ischemic stroke intervention. Journal of the American College of Cardiology 67 (2016), 2631–2644.
126. Kim, D.H., Seo, Y.K., Thambi, T., Moon, G.J., Son, J.P., Li, G., et al. Enhancing neurogenesis and angiogenesis with target delivery of stromal cell derived factor-1alpha using a dual ionic pH-sensitive copolymer. Biomaterials 61 (2015), 115–125.
127. Kim, H.W., Cho, K.J., Lee, S.K., Kim, G.W., Apoptosis signal-regulating kinase 1 (Ask1) targeted small interfering RNA on ischemic neuronal cell death. Brain Research 1412 (2011), 73–78.
128. Kim, J.H., Lee, D.K., Kim, J., Choi, S., Park, W., Ha, K.S., et al. A miRNA-101-3p/Bim axis as a determinant of serum deprivation-induced endothelial cell apoptosis. Cell Death & Disease, 8, 2017, e2808.
129. King, M.D., Whitaker-Lea, W.A., Campbell, J.M., Alleyne, C.H. Jr., Dhandapani, K.M., Necrostatin-1 reduces neurovascular injury after intracerebral hemorrhage. International Journal of Cell Biology, 2014, 2014, 495817.
130. Koh, S.H., Park, H.H., Neurogenesis in stroke recovery. Translational Stroke Research 8 (2017), 3–13.
131. Kokaia, Z., Darsalia, V., Neural stem cell-based therapy for ischemic stroke. Translational Stroke Research 2 (2011), 272–278.
132. Kondoh, Y., Mizusawa, S., Murakami, M., Nakamichi, H., Nagata, K., Fasudil (HA1077), an intracellular calcium antagonist, improves neurological deficits and tissue potassium loss in focal cerebral ischemia in gerbils. Neurological Research 19 (1997), 211–215.
133. Kong, L.L., Hu, J.F., Zhang, W., Yuan, Y.H., Ma, K.L., Han, N., Chen, N.H., Expression of chemokine-like factor 1 after focal cerebral ischemia in the rat. Neuroscience Letters 505 (2011), 14–18.
134. Kong, L.L., Wang, Z.Y., Han, N., Zhuang, X.M., Wang, Z.Z., Li, H., Chen, N.H., Neutralization of chemokine-like factor 1, a novel C-C chemokine, protects against focal cerebral ischemia by inhibiting neutrophil infiltration via MAPK pathways in rats. Journal of Neuroinflammation, 11, 2014, 112.
135. Kong, X., Zhong, M., Su, X., Qin, Q., Su, H., Wan, H., et al. Tetramethylpyrazine promotes migration of neural precursor cells via activating the phosphatidylinositol 3-kinase pathway. Molecular Neurobiology 53 (2016), 6526–6539.
136. Krishnamurthi, R.V., Moran, A.E., Forouzanfar, M.H., Bennett, D.A., Mensah, G.A., Lawes, C.M., et al. The global burden of hemorrhagic stroke: A summary of findings from the GBD 2010 study. Global Heart 9 (2014), 101–106.
137. Kristensen, A.S., Andersen, J., Jorgensen, T.N., Sorensen, L., Eriksen, J., Loland, C.J., Gether, U., SLC6 neurotransmitter transporters: Structure, function, and regulation. Pharmacological Reviews 63 (2011), 585–640.
138. Kumar, V.S., Gopalakrishnan, A., Naziroglu, M., Rajanikant, G.K., Calcium ion—The key player in cerebral ischemia. Current Medicinal Chemistry 21 (2014), 2065–2075.
139. Kumral, A., Baskin, H., Gokmen, N., Yilmaz, O., Genc, K., Genc, S., Ozkan, H., Selective inhibition of nitric oxide in hypoxic-ischemic brain model in newborn rats: Is it an explanation for the protective role of erythropoietin?. Biology of the Neonate 85 (2004), 51–54.
140. Kurzepa, J., Szpetnar, M., Hordyjewska, A., Watroba, S., Golab, P., Boguszewska-Czubara, A., Thrombolytic treatment decreases glutamate/GABA ratio in serum during acute ischaemic stroke: A pilot study. Neurological Research 37 (2015), 934–937.
141. Lai, T.W., Shyu, W.C., Wang, Y.T., Stroke intervention pathways: NMDA receptors and beyond. Trends in Molecular Medicine 17 (2011), 266–275.
142. Lai, T.W., Zhang, S., Wang, Y.T., Excitotoxicity and stroke: Identifying novel targets for neuroprotection. Progress in Neurobiology 115 (2014), 157–188.
143. Lake, E.M., Chaudhuri, J., Thomason, L., Janik, R., Ganguly, M., Brown, M., Stefanovic, B., The effects of delayed reduction of tonic inhibition on ischemic lesion and sensorimotor function. Journal of Cerebral Blood Flow and Metabolism 35 (2015), 1601–1609.
144. Langhauser, F., Kraft, P., Gob, E., Leinweber, J., Schuhmann, M.K., Lorenz, K., et al. Blocking of alpha4 integrin does not protect from acute ischemic stroke in mice. Stroke 45 (2014), 1799–1806.
145. LaRocca, T.J., Sosunov, S.A., Shakerley, N.L., Ten, V.S., Ratner, A.J., Hyperglycemic conditions prime cells for RIP1-dependent necroptosis. The Journal of Biological Chemistry 291 (2016), 13753–13761.
146. LeBien, T.W., Tedder, T.F., B lymphocytes: How they develop and function. Blood 112 (2008), 1570–1580.
147. Lee, M., Ovbiagele, B., Hong, K.S., Wu, Y.L., Lee, J.E., Rao, N.M., Saver, J.L., Effect of blood pressure lowering in early ischemic stroke: Meta-analysis. Stroke 46 (2015), 1883–1889.
148. Lee, S.T., Chu, K., Sinn, D.I., Jung, K.H., Kim, E.H., Kim, S.J., Roh, J.K., Erythropoietin reduces perihematomal inflammation and cell death with eNOS and STAT3 activations in experimental intracerebral hemorrhage. Journal of Neurochemistry 96 (2006), 1728–1739.
149. Li, C., Wang, J., Fang, Y., Liu, Y., Chen, T., Sun, H., Liao, H., Nafamostat mesilate improves function recovery after stroke by inhibiting neuroinflammation in rats. Brain, Behavior, and Immunity 56 (2016), 230–245.
150. Li, H., Colbourne, F., Sun, P., Zhao, Z., Buchan, A.M., Iadecola, C., Caspase inhibitors reduce neuronal injury after focal but not global cerebral ischemia in rats. Stroke 31 (2000), 176–182.
151. Li, H., Qiu, S., Li, X., Li, M., Peng, Y., Autophagy biomarkers in CSF correlates with infarct size, clinical severity and neurological outcome in AIS patients. Journal of Translational Medicine, 13, 2015, 359.
152. Li, H., Wu, J., Shen, H., Yao, X., Liu, C., Pianta, S., Chen, G., Autophagy in hemorrhagic stroke: Mechanisms and clinical implications. Progress in Neurobiology 163–164 (2017), 79–97.
153. Li, L., Chen, J., Sun, S., Zhao, J., Dong, X., Wang, J., Effects of estradiol on autophagy and Nrf-2/ARE signals after cerebral ischemia. Cellular Physiology and Biochemistry 41 (2017), 2027–2036.
154. Li, L., Tan, J., Miao, Y., Lei, P., Zhang, Q., ROS and Autophagy: Interactions and molecular regulatory mechanisms. Cellular and Molecular Neurobiology 35 (2015), 615–621.
155. Li, Q., Zhang, T., Wang, J., Zhang, Z., Zhai, Y., Yang, G.Y., Sun, X., Rapamycin attenuates mitochondrial dysfunction via activation of mitophagy in experimental ischemic stroke. Rapamycin attenuates mitochondrial dysfunction via activation of mitophagy in experimental ischemic stroke 444 (2014), 182–188.
156. Li, L., Tian, J., Long, M.K., Chen, Y., Lu, J., Zhou, C., Wang, T., Protection against experimental stroke by ganglioside GM1 is associated with the inhibition of autophagy. PLoS One, 11, 2016, e0144219.
157. Li, P., Gan, Y., Sun, B.L., Zhang, F., Lu, B., Gao, Y., Hu, X., Adoptive regulatory T-cell therapy protects against cerebral ischemia. Annals of Neurology 74 (2013), 458–471.
158. Li, P., Stetler, R.A., Leak, R.K., Shi, Y., Li, Y., Yu, W., Chen, J., Oxidative stress and DNA damage after cerebral ischemia: Potential therapeutic targets to repair the genome and improve stroke recovery. Neuropharmacology 134 (2017), 208–217.
159. Li, S., Nie, E.H., Yin, Y., Benowitz, L.I., Tung, S., Vinters, H.V., Bahjat, F.R., Stenzel-Poore, M.P., Kawaguchi, R., Coppola, G., et al. GDF10 is a signal for axonal sprouting and functional recovery after stroke. Nature Neuroscience 18 (2015), 1737–1745.
160. Li, T., Zhong, J., Chen, Y., Qiu, X., Zhang, T., Ma, D., Han, W., Expression of chemokine-like factor 1 is upregulated during T lymphocyte activation. Life Sciences 79 (2006), 519–524.
161. Li, Y., Mei, Z., Liu, S., Wang, T., Li, H., Li, X.X., Xu, Z.D., Galanin protects from Caspase-8/12-initiated neuronal apoptosis in the ischemic mouse brain via GalR1. Aging and Disease 8 (2017), 85–100.
162. Li, Y., Zhang, J., Chen, L., Xing, S., Li, J., Zhang, Y., Zeng, J., Ebselen reduces autophagic activation and cell death in the ipsilateral thalamus following focal cerebral infarction. Neuroscience Letters 600 (2015), 206–212.
163. Li, Y.J., Chang, G.Q., Liu, Y., Gong, Y., Yang, C., Wood, K., Yan, Y., Fingolimod alters inflammatory mediators and vascular permeability in intracerebral hemorrhage. Neuroscience Bulletin 31 (2015), 755–762.
164. Lie, M.E., Gowing, E.K., Clausen, R.P., Wellendorph, P., Clarkson, A.N., Inhibition of GABA transporters fails to afford significant protection following focal cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism 38 (2017), 166–173.
165. Liesz, A., Suri-Payer, E., Veltkamp, C., Doerr, H., Sommer, C., Rivest, S., Veltkamp, R., Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nature Medicine 15 (2009), 192–199.
166. Liesz, A., Zhou, W., Mracsko, E., Karcher, S., Bauer, H., Schwarting, S., et al. Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain 134 (2011), 704–720.
167. Liesz, A., Zhou, W., Na, S.Y., Hammerling, G.J., Garbi, N., Karcher, S., Veltkamp, R., Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke. The Journal of Neuroscience 33 (2013), 17350–17362.
168. Liu, D.H., Yuan, F.G., Hu, S.Q., Diao, F., Wu, Y.P., Zong, Y.Y., Zhang, G.Y., Endogenous nitric oxide induces activation of apoptosis signal-regulating kinase 1 via S-nitrosylation in rat hippocampus during cerebral ischemia-reperfusion. Neuroscience 229 (2013), 36–48.
169. Liu, H.S., Shen, H., Luo, Y., Hoffer, B.J., Wang, Y., Yang, Y., Post-treatment with cocaine- and amphetamine-regulated transcript enhances infarct resolution, reinnervation, and angiogenesis in stroke rats - an MRI study. NMR in Biomedicine 29 (2016), 361–370.
170. Liu, L., Yuan, H., Denton, K., Li, X.J., McCullough, L., Li, J., Calcium/calmodulin-dependent protein kinase kinase beta is neuroprotective in stroke in aged mice. The European Journal of Neuroscience 44 (2016), 2139–2146.
171. Liu, S., Wang, X., Li, Y., Xu, L., Yu, X., Ge, L., He, S., Necroptosis mediates TNF-induced toxicity of hippocampal neurons. BioMed Research International, 2014, 2014, 290182.
172. Liu, S.B., Zhao, M.G., Neuroprotective effect of estrogen: Role of nonsynaptic NR2B-containing NMDA receptors. Brain Research Bulletin 93 (2013), 27–31.
173. Liu, Y., Wang, X., Li, W., Zhang, Q., Li, Y., Zhang, Z., et al. A sensitized IGF1 treatment restores corticospinal axon-dependent functions. Neuron 95 (2017), 817–833 (e814).
174. Liu, Y.H., Zhao, Y., Huang, F.Z., Chen, Y.H., Wang, H.X., Bonney, E., Liu, B.Q., Combination of early constraint-induced movement therapy and fasudil enhances motor recovery after ischemic stroke in rats. The International Journal of Neuroscience 126 (2016), 168–173.
175. Liu, Z., Li, Y., Zhang, L., Xin, H., Cui, Y., Hanson, L.R., Chopp, M., Subacute intranasal administration of tissue plasminogen activator increases functional recovery and axonal remodeling after stroke in rats. Neurobiology of Disease 45 (2012), 804–809.
176. Liu, Z., Zhao, Y., Zhang, H., Chai, Q., Cui, Y., Diao, Y., Jiang, G., Excessive variability in systolic blood pressure that is self-measured at home exacerbates the progression of brain white matter lesions and cognitive impairment in the oldest old. Hypertension Research 39 (2016), 245–253.
177. Llovera, G., Hofmann, K., Roth, S., Salas-Perdomo, A., Ferrer-Ferrer, M., Perego, C., et al. Results of a preclinical randomized controlled multicenter trial (pRCT): Anti-CD49d treatment for acute brain ischemia. Science Translational Medicine, 7, 2015 (299-121).
178. Loddick, S.A., Rothwell, N.J., Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. Journal of Cerebral Blood Flow and Metabolism 16 (1996), 932–940.
179. Logallo, N., Novotny, V., Assmus, J., Kvistad, C.E., Alteheld, L., Ronning, O.M., et al. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): A phase 3, randomised, open-label, blinded endpoint trial. Lancet Neurology 16 (2017), 781–788.
180. Low, P.C., Manzanero, S., Mohannak, N., Narayana, V.K., Nguyen, T.H., Kvaskoff, D., et al. PI3Kdelta inhibition reduces TNF secretion and neuroinflammation in a mouse cerebral stroke model. Nature Communications, 5, 2014, 3450.
181. Lu, J., Manaenko, A., Hu, Q., Targeting adult neurogenesis for poststroke therapy. Stem Cells International, 2017, 2017, 5868632.
182. Lu, Q., Harris, V.A., Kumar, S., Mansour, H.M., Black, S.M., Autophagy in neonatal hypoxia ischemic brain is associated with oxidative stress. Redox Biology 6 (2015), 516–523.
183. Lu, W., Man, H., Ju, W., Trimble, W.S., MacDonald, J.F., Wang, Y.T., Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons. Neuron 29 (2001), 243–254.
184. Ma, Q., Zhao, H., Tao, Z., Wang, R., Liu, P., Han, Z., Jia, J., MicroRNA-181c exacerbates brain injury in acute ischemic stroke. Aging and Disease 7 (2016), 705–714.
185. MacDougall, G., Anderton, R.S., Edwards, A.B., Knuckey, N.W., Meloni, B.P., The neuroprotective peptide poly-arginine-12 (R12) reduces cell surface levels of NMDA NR2B receptor subunit in cortical neurons; investigation into the involvement of endocytic mechanisms. Journal of Molecular Neuroscience 61 (2017), 235–246.
186. Macleod, M.R., O'Collins, T., Horky, L.L., Howells, D.W., Donnan, G.A., Systematic review and meta-analysis of the efficacy of melatonin in experimental stroke. Journal of Pineal Research 38 (2005), 35–41.
187. Mallet, R.T., Ryou, M.G., Erythropoietin: Endogenous protection of ischemic brain. Vitamins and Hormones 105 (2017), 197–232.
188. Maniskas, M.E., Roberts, J.M., Aron, I., Fraser, J.F., Bix, G.J., Stroke neuroprotection revisited: Intra-arterial verapamil is profoundly neuroprotective in experimental acute ischemic stroke. Journal of Cerebral Blood Flow and Metabolism 36 (2016), 721–730.
189. Massberg, S., von Andrian, U.H., Fingolimod and sphingosine-1-phosphate—modifiers of lymphocyte migration. The New England Journal of Medicine 355 (2006), 1088–1091.
190. + T cells. Atherosclerosis 197 (2008), 829–839.
191. Maysami, S., Wong, R., Pradillo, J.M., Denes, A., Dhungana, H., Malm, T., et al. A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke. Journal of Cerebral Blood Flow and Metabolism 36 (2016), 596–605.
192. McCullough, L.D., Tarabishy, S., Liu, L., Benashski, S., Xu, Y., Ribar, T., Li, J., Inhibition of calcium/calmodulin-dependent protein kinase kinase beta and calcium/calmodulin-dependent protein kinase IV is detrimental in cerebral ischemia. Stroke 44 (2013), 2559–2566.
193. Medzhitov, R., Toll-like receptors and innate immunity. Nature Reviews. Immunology 1 (2001), 135–145.
194. Minor, K., Phillips, J., Seeds, N.W., Tissue plasminogen activator promotes axonal outgrowth on CNS myelin after conditioned injury. Journal of Neurochemistry 109 (2009), 706–715.
195. Mirzaei, H., Momeni, F., Saadatpour, L., Sahebkar, A., Goodarzi, M., Masoudifar, A., Jaafari, M.R., MicroRNA: Relevance to stroke diagnosis, prognosis, and therapy. Journal of Cellular Physiology 233 (2018), 856–865.
196. Mo, Z.T., Fang, Y.Q., He, Y.P., Zhang, S., beta-Asarone protects PC12 cells against OGD/R-induced injury via attenuating Beclin-1-dependent autophagy. Acta Pharmacol Sin 33 (2012), 737–742.
197. Moskowitz, M.A., Lo, E.H., Iadecola, C., The science of stroke: Mechanisms in search of treatments. Neuron 67 (2010), 181–198.
198. Muldoon, L.L., Alvarez, J.I., Begley, D.J., Boado, R.J., Del Zoppo, G.J., Doolittle, N.D., et al. Immunologic privilege in the central nervous system and the blood-brain barrier. Journal of Cerebral Blood Flow and Metabolism 33 (2013), 13–21.
199. Na, S.Y., Mracsko, E., Liesz, A., Hunig, T., Veltkamp, R., Amplification of regulatory T cells using a CD28 superagonist reduces brain damage after ischemic stroke in mice. Stroke 46 (2015), 212–220.
200. Neuhaus, A.A., Rabie, T., Sutherland, B.A., Papadakis, M., Hadley, G., Cai, R., Buchan, A.M., Importance of preclinical research in the development of neuroprotective strategies for ischemic stroke. JAMA Neurology 71 (2014), 634–639.
201. Ni, J., Wang, X., Chen, S., Liu, H., Wang, Y., Xu, X., Zhen, X., MicroRNA let-7c-5p protects against cerebral ischemia injury via mechanisms involving the inhibition of microglia activation. Brain, Behavior, and Immunity 49 (2015), 75–85.
202. Nogueira, R.G., Jadhav, A.P., Haussen, D.C., Bonafe, A., Budzik, R.F., Bhuva, P., et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. The New England Journal of Medicine 378 (2018), 11–21.
203. Northington, F.J., Chavez-Valdez, R., Graham, E.M., Razdan, S., Gauda, E.B., Martin, L.J., Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. Journal of Cerebral Blood Flow and Metabolism 31 (2011), 178–189.
204. O'Collins, V.E., Macleod, M.R., Donnan, G.A., Horky, L.L., van der Worp, B.H., Howells, D.W., 1,026 experimental treatments in acute stroke. Annals of Neurology 59 (2006), 467–477.
205. Offner, H., Hurn, P.D., A novel hypothesis: Regulatory B lymphocytes shape outcome from experimental stroke. Translational Stroke Research 3 (2012), 324–330.
206. Onetti, Y., Dantas, A.P., Perez, B., Cugota, R., Chamorro, A., Planas, A.M., Jimenez-Altayo, F., Middle cerebral artery remodeling following transient brain ischemia is linked to early postischemic hyperemia: A target of uric acid treatment. American Journal of Physiology. Heart and Circulatory Physiology 308 (2015), H862–H874.
207. Osikov, M.V., Telesheva, L.F., Ageev, Y.I., Antioxidant effect of erythropoietin during experimental chronic renal failure. Bulletin of Experimental Biology and Medicine 160 (2015), 202–204.
208. Overman, J.J., Clarkson, A.N., Wanner, I.B., Overman, W.T., Eckstein, I., Maguire, J.L., Carmichael, S.T., A role for ephrin-A5 in axonal sprouting, recovery, and activity-dependent plasticity after stroke. Proceedings of the National Academy of Sciences of the United States of America 109 (2012), E2230–E2239.
209. Ozawa, S., Kamiya, H., Tsuzuki, K., Glutamate receptors in the mammalian central nervous system. Progress in Neurobiology 54 (1998), 581–618.
210. Palomares, S.M., Cipolla, M.J., Vascular protection following cerebral ischemia and reperfusion. Journal of Neurology and Neurophysiology, 2011, 2011 (pii: S1- 004).
211. Pancioli, A.M., Broderick, J., Brott, T., Tomsick, T., Khoury, J., Bean, J., et al. The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: The CLEAR stroke trial. Stroke 39 (2008), 3268–3276.
212. Pignataro, G., Gala, R., Cuomo, O., Tortiglione, A., Giaccio, L., Castaldo, P., et al. Two sodium/calcium exchanger gene products, NCX1 and NCX3, play a major role in the development of permanent focal cerebral ischemia. Stroke 35 (2004), 2566–2570.
213. Qin, A.P., Liu, C.F., Qin, Y.Y., Hong, L.Z., Xu, M., Yang, L., Zhang, H.L., Autophagy was activated in injured astrocytes and mildly decreased cell survival following glucose and oxygen deprivation and focal cerebral ischemia. Autophagy 6 (2010), 738–753.
214. Radogna, F., Diederich, M., Ghibelli, L., Melatonin: A pleiotropic molecule regulating inflammation. Biochemical Pharmacology 80 (2010), 1844–1852.
215. Rahpeymai, Y., Hietala, M.A., Wilhelmsson, U., Fotheringham, A., Davies, I., Nilsson, A.K., et al. Complement: A novel factor in basal and ischemia-induced neurogenesis. The EMBO Journal 25 (2006), 1364–1374.
216. Rakers, C., Petzold, G.C., Astrocytic calcium release mediates peri-infarct depolarizations in a rodent stroke model. The Journal of Clinical Investigation 127 (2017), 511–516.
217. Ramos, E., Patino, P., Reiter, R.J., Gil-Martin, E., Marco-Contelles, J., Parada, E., Egea, J., Ischemic brain injury: New insights on the protective role of melatonin. Free Radical Biology & Medicine 104 (2017), 32–53.
218. Reitmeir, R., Kilic, E., Kilic, U., Bacigaluppi, M., ElAli, A., Salani, G., Hermann, D.M., Post-acute delivery of erythropoietin induces stroke recovery by promoting perilesional tissue remodelling and contralesional pyramidal tract plasticity. Brain 134 (2011), 84–99.
219. Ren, X., Akiyoshi, K., Dziennis, S., Vandenbark, A.A., Herson, P.S., Hurn, P.D., Offner, H., Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. The Journal of Neuroscience 31 (2011), 8556–8563.
220. Rodriguez-Perea, A.L., Gutierrez-Vargas, J., Cardona-Gomez, G.P., Guarin, C.J., Rojas, M., Hernandez, P.A., Atorvastatin modulates regulatory T cells and attenuates cerebral damage in a model of transient middle cerebral artery occlusion in rats. Journal of Neuroimmune Pharmacology 12 (2017), 152–162.
221. Rha, J.H., Saver, J.L., The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 38 (2007), 967–973.
222. Romanos, E., Planas, A.M., Amaro, S., Chamorro, A., Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke. Journal of Cerebral Blood Flow and Metabolism 27 (2007), 14–20.
223. Ruan, L., Wang, Y., Chen, S.C., Zhao, T., Huang, Q., Hu, Z.L., et al. Metabolite changes in the ipsilateral and contralateral cerebral hemispheres in rats with middle cerebral artery occlusion. Neural Regeneration Research 12 (2017), 931–937.
224. Ryu, J.R., Hong, C.J., Kim, J.Y., Kim, E.K., Sun, W., Yu, S.W., Control of adult neurogenesis by programmed cell death in the mammalian brain. Molecular Brain, 9, 2016, 43.
225. Saeed, S.A., Shad, K.F., Saleem, T., Javed, F., Khan, M.U., Some new prospects in the understanding of the molecular basis of the pathogenesis of stroke. Experimental Brain Research 182 (2007), 1–10.
226. Sakanaka, M., Wen, T.C., Matsuda, S., Masuda, S., Morishita, E., Nagao, M., Sasaki, R., In vivo evidence that erythropoietin protects neurons from ischemic damage. Proceedings of the National Academy of Sciences of the United States of America 95 (1998), 4635–4640.
227. Saqqur, M., Molina, C.A., Salam, A., Siddiqui, M., Ribo, M., Uchino, K., et al. Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: A multicenter transcranial Doppler study. Stroke 38 (2007), 69–74.
228. Satoh, S., Ikegaki, I., Kawasaki, K., Asano, T., Shibuya, M., Pleiotropic effects of the rho-kinase inhibitor fasudil after subarachnoid hemorrhage: A review of preclinical and clinical studies. Current Vascular Pharmacology 12 (2014), 758–765.
229. Saugstad, J.A., Non-coding RNAs in stroke and neuroprotection. Frontiers in Neurology, 6, 2015, 50.
230. Saver, J.L., Goyal, M., Bonafe, A., Diener, H.C., Levy, E.I., Pereira, V.M., et al. Solitaire with the intention for thrombectomy as primary endovascular treatment for acute ischemic stroke (SWIFT PRIME) trial: Protocol for a randomized, controlled, multicenter study comparing the solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke. International Journal of Stroke 10 (2015), 439–448.
231. Schwab, S.R., Pereira, J.P., Matloubian, M., Xu, Y., Huang, Y., Cyster, J.G., Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309 (2005), 1735–1739.
232. Seifert, H.A., Collier, L.A., Chapman, C.B., Benkovic, S.A., Willing, A.E., Pennypacker, K.R., Pro-inflammatory interferon gamma signaling is directly associated with stroke induced neurodegeneration. Journal of Neuroimmune Pharmacology 9 (2014), 679–689.
233. Shen, H., Liu, C., Zhang, D., Yao, X., Zhang, K., Li, H., Chen, G., Role for RIP1 in mediating necroptosis in experimental intracerebral hemorrhage model both in vivo and in vitro. Cell Death & Disease, 8, 2017, e2641.
234. Shen, Z., Zheng, Y., Wu, J., Chen, Y., Wu, X., Zhou, Y., et al. PARK2-dependent mitophagy induced by acidic postconditioning protects against focal cerebral ischemia and extends the reperfusion window. Autophagy 13 (2017), 473–485.
235. Shi, L., Al-Baadani, A., Zhou, K., Shao, A., Xu, S., Chen, S., Zhang, J., PCMT1 ameliorates neuronal apoptosis by inhibiting the activation of MST1 after subarachnoid hemorrhage in rats. Translational Stroke Research, 2017, 10.1007/s12975-017-0540-8 [Epub ahead of print].
236. Shi, L., Liang, F., Li, Y., Shao, A., Zhou, K., Yu, J., Zhang, J., Desmoteplase for acute ischemic stroke within 3 to 9 hours after symptom onset: Evidence from randomized controlled trials. Scientific Reports, 6, 2016, 33989.
237. Shi, R., Weng, J., Zhao, L., Li, X.M., Gao, T.M., Kong, J., Excessive autophagy contributes to neuron death in cerebral ischemia. CNS Neuroscience & Therapeutics 18 (2012), 250–260.
238. Shinjyo, N., Stahlberg, A., Dragunow, M., Pekny, M., Pekna, M., Complement-derived anaphylatoxin C3a regulates in vitro differentiation and migration of neural progenitor cells. Stem Cells 27 (2009), 2824–2832.
239. Shirley, R., Ord, E.N., Work, L.M., Oxidative stress and the use of antioxidants in stroke. Antioxidants (Basel) 3 (2014), 472–501.
240. Siebler, M., Hennerici, M.G., Schneider, D., von Reutern, G.M., Seitz, R.J., Rother, J., Witte, O.W., et al. Safety of Tirofiban in acute ischemic stroke: The SaTIS trial. Stroke 42 (2011), 2388–2392.
241. Singh, N., Hopkins, S.J., Hulme, S., Galea, J.P., Hoadley, M., Vail, A., et al. The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: A phase II randomised controlled trial. Journal of Neuroinflammation, 11, 2014, 1.
242. Son, J.W., Choi, H., Yoo, A., Park, H.H., Kim, Y.S., Lee, K.Y., Koh, S.H., Activation of the phosphatidylinositol 3-kinase pathway plays important roles in reduction of cerebral infarction by cilnidipine. Journal of Neurochemistry 135 (2015), 186–193.
243. Song, J., Cheon, S.Y., Lee, W.T., Park, K.A., Lee, J.E., The effect of ASK1 on vascular permeability and edema formation in cerebral ischemia. Brain Research 1595 (2015), 143–155.
244. Song, J., Cho, K.J., Cheon, S.Y., Kim, S.H., Park, K.A., Lee, W.T., Lee, J.E., Apoptosis signal-regulating kinase 1 (ASK1) is linked to neural stem cell differentiation after ischemic brain injury. Experimental & Molecular Medicine, 45, 2013, e69.
245. Squadrito, G.L., Cueto, R., Splenser, A.E., Valavanidis, A., Zhang, H., Uppu, R.M., Pryor, W.A., Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Archives of Biochemistry and Biophysics 376 (2000), 333–337.
246. Stokowska, A., Atkins, A.L., Moran, J., Pekny, T., Bulmer, L., Pascoe, M.C., et al. Complement peptide C3a stimulates neural plasticity after experimental brain ischaemia. Brain 140 (2017), 353–369.
247. Sun, Y., Gui, H., Li, Q., Luo, Z.M., Zheng, M.J., Duan, J.L., Liu, X., MicroRNA-124 protects neurons against apoptosis in cerebral ischemic stroke. CNS Neuroscience & Therapeutics 19 (2013), 813–819.
248. Sun, Y., Sun, X., Qu, H., Zhao, S., Xiao, T., Zhao, C., Neuroplasticity and behavioral effects of fluoxetine after experimental stroke. Restorative Neurology and Neuroscience 35 (2017), 457–468.
249. Sun, Y., Xu, Y., Geng, L., Caspase-3 inhibitor prevents the apoptosis of brain tissue in rats with acute cerebral infarction. Experimental and Therapeutic Medicine 10 (2015), 133–138.
250. Szydlowska, K., Tymianski, M., Calcium, ischemia and excitotoxicity. Cell Calcium 47 (2010), 122–129.
251. Tajiri, N., Quach, D.M., Kaneko, Y., Wu, S., Lee, D., Lam, T., et al. NSI-189, a small molecule with neurogenic properties, exerts behavioral, and neurostructural benefits in stroke rats. Journal of Cellular Physiology 232 (2017), 2731–2740.
252. Tang, F., Guo, S., Liao, H., Yu, P., Wang, L., Song, X., Yang, Q., Resveratrol enhances neurite outgrowth and synaptogenesis via sonic hedgehog signaling following oxygen-glucose deprivation/reoxygenation injury. Cellular Physiology and Biochemistry 43 (2017), 852–869.
253. Tang, N., Wu, J., Zhu, H., Yan, H., Guo, Y., Cai, Y., et al. Genetic mutation of GluN2B protects brain cells against stroke damages. Molecular Neurobiology 55 (2017), 2979–2990.
254. Tang, Y.C., Tian, H.X., Yi, T., Chen, H.B., The critical roles of mitophagy in cerebral ischemia. Protein & Cell 7 (2016), 699–713.
255. Tang, Z., Li, S., Han, P., Yin, J., Gan, Y., Liu, Q., Shi, J., Pertussis toxin reduces calcium influx to protect ischemic stroke in a middle cerebral artery occlusion model. Journal of Neurochemistry 135 (2015), 998–1006.
256. Tsai, S.Y., Papadopoulos, C.M., Schwab, M.E., Kartje, G.L., Delayed anti-nogo-a therapy improves function after chronic stroke in adult rats. Stroke 42 (2011), 186–190.
257. Uddin, M.S., Hoque, M.I., Uddin, M.K., Kamol, S.A., Chowdhury, R.H., Circadian rhythm of onset of stroke - in 50 cases of ischemic stroke. Mymensingh Medical Journal 24 (2015), 121–126.
258. Vahidy, F., Schabitz, W.R., Fisher, M., Aronowski, J., Reporting standards for preclinical studies of stroke therapy. Stroke 47 (2016), 2435–2438.
259. Venna, V.R., Li, J., Hammond, M.D., Mancini, N.S., McCullough, L.D., Chronic metformin treatment improves post-stroke angiogenesis and recovery after experimental stroke. The European Journal of Neuroscience 39 (2014), 2129–2138.
260. Vidale, S., Agostoni, E., Thrombolysis in acute ischaemic stroke. Brain, 137, 2014, e281.
261. Vizi, E.S., Kisfali, M., Lorincz, T., Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: Evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects. Brain Research Bulletin 93 (2013), 32–38.
262. Waltimo, T., Haapaniemi, E., Surakka, I.L., Melkas, S., Sairanen, T., Sibolt, G., Strbian, D., Post-thrombolytic blood pressure and symptomatic intracerebral hemorrhage. European Journal of Neurology 23 (2016), 1757–1762.
263. Wang, H., Li, P., Xu, N., Zhu, L., Cai, M., Yu, W., Gao, Y., Paradigms and mechanisms of inhalational anesthetics mediated neuroprotection against cerebral ischemic stroke. Medical Gas Research 6 (2016), 194–205.
264. Wang, J., Cao, B., Han, D., Sun, M., Feng, J., Long non-coding RNA H19 induces cerebral ischemia reperfusion injury via activation of autophagy. Aging and Disease 8 (2017), 71–84.
265. Wang, P., Liang, J., Li, Y., Li, J., Yang, X., Zhang, X., Li, J., Down-regulation of miRNA-30a alleviates cerebral ischemic injury through enhancing beclin 1-mediated autophagy. Neurochemical Research 39 (2014), 1279–1291.
266. Wang, P., Liang, X., Lu, Y., Zhao, X., Liang, J., MicroRNA-93 downregulation ameliorates cerebral ischemic injury through the Nrf2/HO-1 defense pathway. Neurochemical Research 41 (2016), 2627–2635.
267. Wang, Y., Wang, Y., Zhao, X., Liu, L., Wang, D., Wang, C., et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. The New England Journal of Medicine 369 (2013), 11–19.
268. Wang, Y.Z., Wang, J.J., Huang, Y., Liu, F., Zeng, W.Z., Li, Y., Xu, T.L., Tissue acidosis induces neuronal necroptosis via ASIC1a channel independent of its ionic conduction. eLife, 4, 2015.
269. Wang, Z., Shi, X.Y., Yin, J., Zuo, G., Zhang, J., Chen, G., Role of autophagy in early brain injury after experimental subarachnoid hemorrhage. Journal of Molecular Neuroscience 46 (2012), 192–202.
270. Wang, Z., Xue, Y., Jiao, H., Liu, Y., Wang, P., Doxycycline-mediated protective effect against focal cerebral ischemia-reperfusion injury through the modulation of tight junctions and PKCdelta signaling in rats. Journal of Molecular Neuroscience 47 (2012), 89–100.
271. Wardlaw, J.M., Murray, V., Berge, E., del Zoppo, G.J., Thrombolysis for acute ischaemic stroke. Cochrane Database of Systematic Reviews, 7, 2014, CD000213.
272. Watson, N., Diamandis, T., Gonzales-Portillo, C., Reyes, S., Borlongan, C.V., Melatonin as an antioxidant for stroke neuroprotection. Cell Transplantation 25 (2016), 883–891.
273. Wei, G., Huang, Y., Li, F., Zeng, F., Li, Y., Deng, R., Chen, D., XingNaoJing, prescription of traditional Chinese medicine, prevents autophagy in experimental stroke by repressing p53-DRAM pathway. BMC Complementary and Alternative Medicine, 15, 2015, 377.
274. Wei, K., Wang, P., Miao, C.Y., A double-edged sword with therapeutic potential: An updated role of autophagy in ischemic cerebral injury. CNS Neuroscience & Therapeutics 18 (2012), 879–886.
275. Weis, S.N., Toniazzo, A.P., Ander, B.P., Zhan, X., Careaga, M., Ashwood, P., Sharp, F.R., Autophagy in the brain of neonates following hypoxia-ischemia shows sex- and region-specific effects. Neuroscience 256 (2014), 201–209.
276. Wiersma, A.M., Fouad, K., Winship, I.R., Enhancing spinal plasticity amplifies the benefits of rehabilitative training and improves recovery from stroke. The Journal of Neuroscience 37 (2017), 10983–10997.
277. Woitzik, J., Pinczolits, A., Hecht, N., Sandow, N., Scheel, M., Drenckhahn, C., Vajkoczy, P., Excitotoxicity and metabolic changes in association with infarct progression. Stroke 45 (2014), 1183–1185.
278. Won, S., Lee, J.H., Wali, B., Stein, D.G., Sayeed, I., Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: Involvement of the VEGF-MMP pathway. Journal of Cerebral Blood Flow and Metabolism 34 (2014), 72–80.
279. Wu, H.J., Wu, C., Niu, H.J., Wang, K., Mo, L.J., Shao, A.W., Wang, Y.R., Neuroprotective mechanisms of melatonin in hemorrhagic stroke. Cellular and Molecular Neurobiology 37 (2017), 1173–1185.
280. Wu, X., Li, L., Zhang, L., Wu, J., Zhou, Y., Zhou, Y., Zhao, J., Inhibition of thioredoxin-1 with siRNA exacerbates apoptosis by activating the ASK1-JNK/p38 pathway in brain of a stroke model rats. Brain Research 1599 (2015), 20–31.
281. Xu, X., Chua, C.C., Zhang, M., Geng, D., Liu, C.F., Hamdy, R.C., Chua, B.H., The role of PARP activation in glutamate-induced necroptosis in HT-22 cells. Brain Research 1343 (2010), 206–212.
282. Xu, J., Wang, H., Won, S.J., Basu, J., Kapfhamer, D., Swanson, R.A., Microglial activation induced by the alarmin S100B is regulated by poly(ADP-ribose) polymerase-1. Glia 64 (2016), 1869–1878.
283. Xu, Q., Deng, F., Xing, Z., Wu, Z., Cen, B., Xu, S., et al. Long non-coding RNA C2dat1 regulates CaMKIIdelta expression to promote neuronal survival through the NF-kappaB signaling pathway following cerebral ischemia. Cell Death & Disease, 7, 2016, e2173.
284. Xu, W., Mu, X., Wang, H., Song, C., Ma, W., Jolkkonen, J., Zhao, C., Chloride co-transporter NKCC1 inhibitor bumetanide enhances neurogenesis and behavioral recovery in rats after experimental stroke. Molecular Neurobiology 54 (2017), 2406–2414.
285. Xu, X., Chua, K.W., Chua, C.C., Liu, C.F., Hamdy, R.C., Chua, B.H., Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury. Brain Research 1355 (2010), 189–194.
286. Xu, X., Wen, Z., Zhao, N., Xu, X., Wang, F., Gao, J., Liu, X., MicroRNA-1906, a novel regulator of toll-like receptor 4, ameliorates ischemic injury after experimental stroke in mice. The Journal of Neuroscience 37 (2017), 10498–10515.
287. Xu, Y., Wang, J., Song, X., Qu, L., Wei, R., He, F., Luo, B., RIP3 induces ischemic neuronal DNA degradation and programmed necrosis in rat via AIF. Scientific Reports, 6, 2016, 29362.
288. Xu, Z., Croslan, D.R., Harris, A.E., Ford, G.D., Ford, B.D., Extended therapeutic window and functional recovery after intraarterial administration of neuregulin-1 after focal ischemic stroke. Journal of Cerebral Blood Flow and Metabolism 26 (2006), 527–535.
289. Xuan, M., Okazaki, M., Iwata, N., Asano, S., Kamiuchi, S., Matsuzaki, H., Hibino, Y., Chronic treatment with a water-soluble extract from the culture medium of Ganoderma lucidum mycelia prevents apoptosis and necroptosis in hypoxia/ischemia-induced injury of type 2 diabetic mouse brain. Evidence-based Complementary and Alternative Medicine, 2015, 2015, 865986.
290. Yan, P., Zhu, A., Liao, F., Xiao, Q., Kraft, A., Gonzales, E., Lee, J.M., Minocycline reduces spontaneous hemorrhage in mouse models of cerebral amyloid angiopathy. Stroke 46 (2015), 1633–1640.
291. Yan, T., Chopp, M., Ye, X., Liu, Z., Zacharek, A., Cui, Y., Chen, J., Niaspan increases axonal remodeling after stroke in type 1 diabetes rats. Neurobiology of Disease 46 (2012), 157–164.
292. Yang, F., Zhou, L., Wang, D., Wang, Z., Huang, Q.Y., Minocycline ameliorates hypoxia-induced blood-brain barrier damage by inhibition of HIF-1alpha through SIRT-3/PHD-2 degradation pathway. Neuroscience 304 (2015), 250–259.
293. Yang, T., Sun, Y., Zhang, F., Anti-oxidative aspect of inhaled anesthetic gases against acute brain injury. Medical Gas Research 6 (2016), 223–226.
294. Yang, X., Tang, X., Sun, P., Shi, Y., Liu, K., Hassan, S.H., Yin, K.J., MicroRNA-15a/16-1 antagomir ameliorates ischemic brain injury in experimental stroke. Stroke 48 (2017), 1941–1947.
295. Yang, X.S., Yi, T.L., Zhang, S., Xu, Z.W., Yu, Z.Q., Sun, H.T., Cheng, S.X., Hypoxia-inducible factor-1 alpha is involved in RIP-induced necroptosis caused by in vitro and in vivo ischemic brain injury. Scientific Reports, 7, 2017, 5818.
296. Yang, Y., Thompson, J.F., Taheri, S., Salayandia, V.M., McAvoy, T.A., Hill, J.W., Rosenberg, G.A., Early inhibition of MMP activity in ischemic rat brain promotes expression of tight junction proteins and angiogenesis during recovery. Journal of Cerebral Blood Flow and Metabolism 33 (2013), 1104–1114.
297. Yang, Z., Zhong, L., Zhong, S., Xian, R., Yuan, B., Hypoxia induces microglia autophagy and neural inflammation injury in focal cerebral ischemia model. Experimental and Molecular Pathology 98 (2015), 219–224.
298. Yanli, L., Xizhou, Z., Yan, W., Bo, Z., Yunhong, Z., Zicheng, L., et al. Clonidine preconditioning alleviated focal cerebral ischemic insult in rats via up-regulating p-NMDAR1 and down-regulating NMDAR2A/p-NMDAR2B. European Journal of Pharmacology 793 (2016), 89–94.
299. Yemisci, M., Gursoy-Ozdemir, Y., Vural, A., Can, A., Topalkara, K., Dalkara, T., Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nature Medicine 15 (2009), 1031–1037.
300. Yin, B., Xu, Y., Wei, R.L., He, F., Luo, B.Y., Wang, J.Y., Inhibition of receptor-interacting protein 3 upregulation and nuclear translocation involved in Necrostatin-1 protection against hippocampal neuronal programmed necrosis induced by ischemia/reperfusion injury. Brain Research 1609 (2015), 63–71.
301. Yoo, S.J., Cho, B., Lee, D., Son, G., Lee, Y.B., Soo Han, H., Moon, C., The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage. Cell Death & Disease, 8, 2017, e3003.
302. Yoon, J.S., Lee, J.H., Tweedie, D., Mughal, M.R., Chigurupati, S., Greig, N.H., Mattson, M.P., 3,6′-dithiothalidomide improves experimental stroke outcome by suppressing neuroinflammation. Journal of Neuroscience Research 91 (2013), 671–680.
303. Yu, S.J., Tseng, K.Y., Shen, H., Harvey, B.K., Airavaara, M., Wang, Y., Local administration of AAV-BDNF to subventricular zone induces functional recovery in stroke rats. PLoS One, 8, 2013, e81750.
304. Yu, Z.F., Bruce-Keller, A.J., Goodman, Y., Mattson, M.P., Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. Journal of Neuroscience Research 53 (1998), 613–625.
305. Yuan, J., Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke. Apoptosis 14 (2009), 469–477.
306. Zhai, W.W., Sun, L., Yu, Z.Q., Chen, G., Hyperbaric oxygen therapy in experimental and clinical stroke. Medical Gas Research 6 (2016), 111–118.
307. Zhang, J., Mu, X., Breker, D.A., Li, Y., Gao, Z., Huang, Y., Atorvastatin treatment is associated with increased BDNF level and improved functional recovery after atherothrombotic stroke. The International Journal of Neuroscience 127 (2017), 92–97.
308. Zhang, N., Zhong, J., Han, S., Li, Y., Yin, Y., Li, J., MicroRNA-378 alleviates cerebral ischemic injury by negatively regulating apoptosis executioner Caspase-3. International Journal of Molecular Sciences, 17, 2016 (pii: E1427).
309. Zhang, Y., Han, B., He, Y., Li, D., Ma, X., Liu, Q., Hao, J., MicroRNA-132 attenuates neurobehavioral and neuropathological changes associated with intracerebral hemorrhage in mice. Neurochemistry International 107 (2017), 182–190.
310. 2+/CaMKII/CREB signaling pathway. Molecules, 22, 2017 (pii: E359).
311. Zhang, X.M., Zhang, L., Wang, G., Niu, W., He, Z., Ding, L., Jia, J., Suppression of mitochondrial fission in experimental cerebral ischemia: The potential neuroprotective target of p38 MAPK inhibition. Neurochem Int 90 (2015), 1–8.
312. Zhang, Z., Chopp, M., Neural stem cells and ischemic brain. Journal of Stroke 18 (2016), 267–272.
313. Zhao, F., Qu, Y., Wang, H., Huang, L., Zhu, J., Li, S., Mu, D., The effect of miR-30d on apoptosis and autophagy in cultured astrocytes under oxygen-glucose deprivation. Brain Research 1671 (2017), 67–76.
314. Zhao, F., Qu, Y., Zhu, J., Zhang, L., Huang, L., Liu, H., Mu, D., miR-30d-5p plays an important role in autophagy and apoptosis in developing rat brains after hypoxic-ischemic injury. Journal of Neuropathology and Experimental Neurology 76 (2017), 709–719.
315. Zhao, H., Wang, J., Gao, L., Wang, R., Liu, X., Gao, Z., et al. MiRNA-424 protects against permanent focal cerebral ischemia injury in mice involving suppressing microglia activation. Stroke 44 (2013), 1706–1713.
316. Zheng, Y., Hou, J., Liu, J., Yao, M., Li, L., Zhang, B., Wang, Z., Inhibition of autophagy contributes to melatonin-mediated neuroprotection against transient focal cerebral ischemia in rats. Journal of Pharmacological Sciences 124 (2014), 354–364.
317. Zhou, W., Yuan, J., SnapShot: Necroptosis. Cell, 158, 2014, 464-464.
318. Zhou, X.Y., Luo, Y., Zhu, Y.M., Liu, Z.H., Kent, T.A., Rong, J.G., et al. Inhibition of autophagy blocks cathepsins-tBid-mitochondrial apoptotic signaling pathway via stabilization of lysosomal membrane in ischemic astrocytes. Cell Death & Disease, 8, 2017, e2618.
319. Zhu, X., Tao, L., Tejima-Mandeville, E., Qiu, J., Park, J., Garber, K., Whalen, M.J., Plasmalemma permeability and necrotic cell death phenotypes after intracerebral hemorrhage in mice. Stroke 43 (2012), 524–531.
320. Zille, M., Karuppagounder, S.S., Chen, Y., Gough, P.J., Bertin, J., Finger, J., Ratan, R.R., Neuronal death after hemorrhagic stroke in vitro and in vivo shares features of ferroptosis and necroptosis. Stroke 48 (2017), 1033–1043.
321. Zundorf, G., Reiser, G., Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection. Antioxidants & Redox Signaling 14 (2011), 1275–1288.